BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keiser NW, Engelhardt JF. New animal models of cystic fibrosis: what are they teaching us? Curr Opin Pulm Med 2011;17:478-83. [PMID: 21857224 DOI: 10.1097/MCP.0b013e32834b14c9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 59] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Grubb BR, Livraghi-butrico A. Animal models of cystic fibrosis in the era of highly effective modulator therapies. Current Opinion in Pharmacology 2022;64:102235. [DOI: 10.1016/j.coph.2022.102235] [Reference Citation Analysis]
2 Yu Q, Liu X, Liu Y, Riederer B, Li T, Tian DA, Tuo B, Shull G, Seidler U. Defective small intestinal anion secretion, dipeptide absorption, and intestinal failure in suckling NBCe1-deficient mice. Pflugers Arch 2016;468:1419-32. [PMID: 27228994 DOI: 10.1007/s00424-016-1836-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
3 Lavelle GM, White MM, Browne N, McElvaney NG, Reeves EP. Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences. Biomed Res Int 2016;2016:5258727. [PMID: 27340661 DOI: 10.1155/2016/5258727] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 11.2] [Reference Citation Analysis]
4 Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16:45-56. [PMID: 25404111 DOI: 10.1038/nrg3849] [Cited by in Crossref: 475] [Cited by in F6Publishing: 406] [Article Influence: 59.4] [Reference Citation Analysis]
5 Castellani C, Assael BM. Cystic fibrosis: a clinical view. Cell Mol Life Sci. 2017;74:129-140. [PMID: 27709245 DOI: 10.1007/s00018-016-2393-9] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 16.0] [Reference Citation Analysis]
6 Xu J, Zhang J, Yang D, Song J, Pallas B, Zhang C, Hu J, Peng X, Christensen ND, Han R, Chen YE. Gene Editing in Rabbits: Unique Opportunities for Translational Biomedical Research. Front Genet 2021;12:642444. [PMID: 33584832 DOI: 10.3389/fgene.2021.642444] [Reference Citation Analysis]
7 Sharma J, Abbott J, Klaskala L, Zhao G, Birket SE, Rowe SM. A Novel G542X CFTR Rat Model of Cystic Fibrosis Is Sensitive to Nonsense Mediated Decay. Front Physiol 2020;11:611294. [PMID: 33391025 DOI: 10.3389/fphys.2020.611294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Langendonk RF, Neill DR, Fothergill JL. The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies. Front Cell Infect Microbiol 2021;11:665759. [PMID: 33937104 DOI: 10.3389/fcimb.2021.665759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ribeiro CM, Lubamba BA. Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation. Int J Mol Sci 2017;18:E118. [PMID: 28075361 DOI: 10.3390/ijms18010118] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
10 Sun X, Yi Y, Liang B, Yang Y, He N, Ode KL, Uc A, Wang K, Gibson-Corley KN, Engelhardt JF, Norris AW. Incretin dysfunction and hyperglycemia in cystic fibrosis: Role of acyl-ghrelin. J Cyst Fibros 2019;18:557-65. [PMID: 30738804 DOI: 10.1016/j.jcf.2019.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Yan Z, Sun X, Evans IA, Tyler SR, Song Y, Liu X, Sui H, Engelhardt JF. Postentry processing of recombinant adeno-associated virus type 1 and transduction of the ferret lung are altered by a factor in airway secretions. Hum Gene Ther 2013;24:786-96. [PMID: 23948055 DOI: 10.1089/hum.2013.137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Oliver KE, Han ST, Sorscher EJ, Cutting GR. Transformative therapies for rare CFTR missense alleles. Curr Opin Pharmacol 2017;34:76-82. [PMID: 29032041 DOI: 10.1016/j.coph.2017.09.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chen J, Zeng W, Pan W, Peng C, Zhang J, Su J, Long W, Zhao H, Zuo X, Xie X, Wu J, Nie L, Zhao HY, Wei HJ, Chen X. Symptoms of systemic lupus erythematosus are diagnosed in leptin transgenic pigs. PLoS Biol 2018;16:e2005354. [PMID: 30169503 DOI: 10.1371/journal.pbio.2005354] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Keeling KM, Xue X, Gunn G, Bedwell DM. Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet 2014;15:371-94. [PMID: 24773318 DOI: 10.1146/annurev-genom-091212-153527] [Cited by in Crossref: 162] [Cited by in F6Publishing: 144] [Article Influence: 20.3] [Reference Citation Analysis]
15 Rotti PG, Xie W, Poudel A, Yi Y, Sun X, Tyler SR, Uc A, Norris AW, Hara M, Engelhardt JF, Gibson-Corley KN. Pancreatic and Islet Remodeling in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Ferrets. Am J Pathol 2018;188:876-90. [PMID: 29366680 DOI: 10.1016/j.ajpath.2017.12.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
16 Fontés G, Ghislain J, Benterki I, Zarrouki B, Trudel D, Berthiaume Y, Poitout V. The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice. Diabetes 2015;64:4112-22. [PMID: 26283735 DOI: 10.2337/db14-0810] [Cited by in Crossref: 25] [Cited by in F6Publishing: 1] [Article Influence: 3.6] [Reference Citation Analysis]
17 Sealy RE, Surman SL, Vogel P, Hurwitz JL. Might Routine Vitamin A Monitoring in Cystic Fibrosis Patients Reduce Virus-Mediated Lung Pathology? Front Immunol 2021;12:704391. [PMID: 34858393 DOI: 10.3389/fimmu.2021.704391] [Reference Citation Analysis]
18 Mariotti V, Strazzabosco M, Fabris L, Calvisi DF. Animal models of biliary injury and altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1254-1261. [PMID: 28709963 DOI: 10.1016/j.bbadis.2017.06.027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
19 Hull-Ryde EA, Minges JT, Martino MEB, Kato T, Norris-Drouin JL, Ribeiro CMP. IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation. Int J Mol Sci 2021;22:3063. [PMID: 33802742 DOI: 10.3390/ijms22063063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Hunt WR, Zughaier SM, Guentert DE, Shenep MA, Koval M, McCarty NA, Hansen JM. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes. Am J Physiol Lung Cell Mol Physiol 2014;306:L43-9. [PMID: 24097557 DOI: 10.1152/ajplung.00224.2013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
21 Semaniakou A, Croll RP, Chappe V. Animal Models in the Pathophysiology of Cystic Fibrosis. Front Pharmacol 2018;9:1475. [PMID: 30662403 DOI: 10.3389/fphar.2018.01475] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
22 Mergiotti M, Murabito A, Prono G, Ghigo A. CFTR Modulator Therapy for Rare CFTR Mutants. JoR 2022;2:59-76. [DOI: 10.3390/jor2020005] [Reference Citation Analysis]
23 Carolan LA, Butler J, Rockman S, Guarnaccia T, Hurt AC, Reading P, Kelso A, Barr I, Laurie KL. TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses. J Virol Methods 2014;205:38-52. [PMID: 24797460 DOI: 10.1016/j.jviromet.2014.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
24 Bayes HK, Ritchie N, Irvine S, Evans TJ. A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection. Sci Rep 2016;6:35838. [PMID: 27804985 DOI: 10.1038/srep35838] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
25 Chanoux RA, Rubenstein RC. Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis. Front Pharmacol 2012;3:137. [PMID: 22822398 DOI: 10.3389/fphar.2012.00137] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
26 Sun X, Olivier AK, Yi Y, Pope CE, Hayden HS, Liang B, Sui H, Zhou W, Hager KR, Zhang Y, Liu X, Yan Z, Fisher JT, Keiser NW, Song Y, Tyler SR, Goeken JA, Kinyon JM, Radey MC, Fligg D, Wang X, Xie W, Lynch TJ, Kaminsky PM, Brittnacher MJ, Miller SI, Parekh K, Meyerholz DK, Hoffman LR, Frana T, Stewart ZA, Engelhardt JF. Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets. Am J Pathol. 2014;184:1309-1322. [PMID: 24637292 DOI: 10.1016/j.ajpath.2014.01.035] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
27 Choi SH, Engelhardt JF. Gene Therapy for Cystic Fibrosis: Lessons Learned and Paths Forward. Mol Ther 2021;29:428-30. [PMID: 33472034 DOI: 10.1016/j.ymthe.2021.01.010] [Reference Citation Analysis]
28 Tang Y, Yan Z, Engelhardt JF. Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease. Hum Gene Ther 2020;31:524-37. [PMID: 32138545 DOI: 10.1089/hum.2020.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
29 Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012;18:509-519. [PMID: 22481418 DOI: 10.1038/nm.2715] [Cited by in Crossref: 311] [Cited by in F6Publishing: 298] [Article Influence: 31.1] [Reference Citation Analysis]
30 Olivier AK, Yi Y, Sun X, Sui H, Liang B, Hu S, Xie W, Fisher JT, Keiser NW, Lei D, Zhou W, Yan Z, Li G, Evans TI, Meyerholz DK, Wang K, Stewart ZA, Norris AW, Engelhardt JF. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest 2012;122:3755-68. [PMID: 22996690 DOI: 10.1172/JCI60610] [Cited by in Crossref: 93] [Cited by in F6Publishing: 61] [Article Influence: 9.3] [Reference Citation Analysis]
31 Rosen BH, Chanson M, Gawenis LR, Liu J, Sofoluwe A, Zoso A, Engelhardt JF. Animal and model systems for studying cystic fibrosis. J Cyst Fibros 2018;17:S28-34. [PMID: 28939349 DOI: 10.1016/j.jcf.2017.09.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 8.6] [Reference Citation Analysis]
32 Birket SE, Davis JM, Fernandez CM, Tuggle KL, Oden AM, Chu KK, Tearney GJ, Fanucchi MV, Sorscher EJ, Rowe SM. Development of an airway mucus defect in the cystic fibrosis rat. JCI Insight 2018;3:97199. [PMID: 29321377 DOI: 10.1172/jci.insight.97199] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
33 Schwerin SC, Hutchinson EB, Radomski KL, Ngalula KP, Pierpaoli CM, Juliano SL. Establishing the ferret as a gyrencephalic animal model of traumatic brain injury: Optimization of controlled cortical impact procedures. J Neurosci Methods 2017;285:82-96. [PMID: 28499842 DOI: 10.1016/j.jneumeth.2017.05.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
34 Tuszynski JA, Winter P, White D, Tseng CY, Sahu KK, Gentile F, Spasevska I, Omar SI, Nayebi N, Churchill CD, Klobukowski M, El-Magd RM. Mathematical and computational modeling in biology at multiple scales. Theor Biol Med Model 2014;11:52. [PMID: 25542608 DOI: 10.1186/1742-4682-11-52] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
35 Ribeiro CMP, Gentzsch M. Impact of Airway Inflammation on the Efficacy of CFTR Modulators. Cells 2021;10:3260. [PMID: 34831482 DOI: 10.3390/cells10113260] [Reference Citation Analysis]
36 Papaioannou E, Utari PD, Quax WJ. Choosing an appropriate infection model to study quorum sensing inhibition in Pseudomonas infections. Int J Mol Sci. 2013;14:19309-19340. [PMID: 24065108 DOI: 10.3390/ijms140919309] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
37 Birket SE, Davis JM, Fernandez-Petty CM, Henderson AG, Oden AM, Tang L, Wen H, Hong J, Fu L, Chambers A, Fields A, Zhao G, Tearney GJ, Sorscher EJ, Rowe SM. Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR. Am J Respir Crit Care Med 2020;202:1271-82. [PMID: 32584141 DOI: 10.1164/rccm.202002-0369OC] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
38 Cafora M, Deflorian G, Forti F, Ferrari L, Binelli G, Briani F, Ghisotti D, Pistocchi A. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model. Sci Rep 2019;9:1527. [PMID: 30728389 DOI: 10.1038/s41598-018-37636-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
39 Lee RJ, Foskett JK. Why mouse airway submucosal gland serous cells do not secrete fluid in response to cAMP stimulation. J Biol Chem 2012;287:38316-26. [PMID: 22989883 DOI: 10.1074/jbc.M112.412817] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
40 Kaza N, Raju SV, Cadillac JM, Trombley JA, Rasmussen L, Tang L, Dohm E, Harrod KS, Rowe SM. Use of ferrets for electrophysiologic monitoring of ion transport. PLoS One 2017;12:e0186984. [PMID: 29077751 DOI: 10.1371/journal.pone.0186984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
41 Lebeaux D, Chauhan A, Rendueles O, Beloin C. From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. Pathogens 2013;2:288-356. [PMID: 25437038 DOI: 10.3390/pathogens2020288] [Cited by in Crossref: 240] [Cited by in F6Publishing: 207] [Article Influence: 26.7] [Reference Citation Analysis]
42 West J, Gill WW. Genome Editing in Large Animals. J Equine Vet Sci 2016;41:1-6. [PMID: 27766006 DOI: 10.1016/j.jevs.2016.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
43 Niknahad A, Shahkar L, Kompani F, Montazeri M, Ahani Azar A. Comparative Study of Urinary Minerals and Their Effect on Stone Formation in Two Groups of Cystic Fibrosis (CF) and Healthy Children. Nephro-Urol Mon 2020;12. [DOI: 10.5812/numonthly.105530] [Reference Citation Analysis]
44 Fontés G, Ghislain J, Benterki I, Zarrouki B, Trudel D, Berthiaume Y, Poitout V. The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice. Diabetes 2015;64:4112-22. [PMID: 26283735 DOI: 10.2337/db14-0810] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
45 Yan Z, Feng Z, Sun X, Zhang Y, Zou W, Wang Z, Jensen-Cody C, Liang B, Park SY, Qiu J, Engelhardt JF. Human Bocavirus Type-1 Capsid Facilitates the Transduction of Ferret Airways by Adeno-Associated Virus Genomes. Hum Gene Ther 2017;28:612-25. [PMID: 28490200 DOI: 10.1089/hum.2017.060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
46 Kim N, Duncan GA, Hanes J, Suk JS. Barriers to inhaled gene therapy of obstructive lung diseases: A review. J Control Release 2016;240:465-88. [PMID: 27196742 DOI: 10.1016/j.jconrel.2016.05.031] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
47 Cifani N, Pompili B, Anile M, Patella M, Diso D, Venuta F, Cimino G, Quattrucci S, Di Domenico EG, Ascenzioni F, Del Porto P. Reactive-oxygen-species-mediated P. aeruginosa killing is functional in human cystic fibrosis macrophages. PLoS One 2013;8:e71717. [PMID: 23977124 DOI: 10.1371/journal.pone.0071717] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
48 Harrison PT, Sanz DJ, Hollywood JA. Impact of gene editing on the study of cystic fibrosis. Hum Genet 2016;135:983-92. [PMID: 27325484 DOI: 10.1007/s00439-016-1693-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
49 Yan Z, Stewart ZA, Sinn PL, Olsen JC, Hu J, McCray PB Jr, Engelhardt JF. Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy. Hum Gene Ther Clin Dev 2015;26:38-49. [PMID: 25675143 DOI: 10.1089/humc.2014.154] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
50 Tucker TA, Fortenberry JA, Zsembery A, Schwiebert LM, Schwiebert EM. The ΔF508-CFTR mutation inhibits wild-type CFTR processing and function when co-expressed in human airway epithelia and in mouse nasal mucosa. BMC Physiol 2012;12:12. [PMID: 22999299 DOI: 10.1186/1472-6793-12-12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
51 Lara-Reyna S, Scambler T, Holbrook J, Wong C, Jarosz-Griffiths HH, Martinon F, Savic S, Peckham D, McDermott MF. Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation. Front Immunol 2019;10:1789. [PMID: 31428093 DOI: 10.3389/fimmu.2019.01789] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
52 Witko-Sarsat V. Neutrophils in the innate immunity conundrum of cystic fibrosis: a CFTR-related matter? J Innate Immun 2013;5:195-6. [PMID: 23548924 DOI: 10.1159/000350215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
53 Short FL, Murdoch SL, Ryan RP. Polybacterial human disease: the ills of social networking. Trends Microbiol 2014;22:508-16. [PMID: 24938173 DOI: 10.1016/j.tim.2014.05.007] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 10.5] [Reference Citation Analysis]
54 Keiser NW, Birket SE, Evans IA, Tyler SR, Crooke AK, Sun X, Zhou W, Nellis JR, Stroebele EK, Chu KK, Tearney GJ, Stevens MJ, Harris JK, Rowe SM, Engelhardt JF. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs. Am J Respir Cell Mol Biol 2015;52:683-94. [PMID: 25317669 DOI: 10.1165/rcmb.2014-0250OC] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 8.6] [Reference Citation Analysis]
55 Fisher JT, Tyler SR, Zhang Y, Lee BJ, Liu X, Sun X, Sui H, Liang B, Luo M, Xie W, Yi Y, Zhou W, Song Y, Keiser N, Wang K, de Jonge HR, Engelhardt JF. Bioelectric characterization of epithelia from neonatal CFTR knockout ferrets. Am J Respir Cell Mol Biol 2013;49:837-44. [PMID: 23782101 DOI: 10.1165/rcmb.2012-0433OC] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
56 Lundblad LKA, Robichaud A. Oscillometry of the respiratory system: a translational opportunity not to be missed. Am J Physiol Lung Cell Mol Physiol 2021;320:L1038-56. [PMID: 33822645 DOI: 10.1152/ajplung.00222.2020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Lovewell RR, Patankar YR, Berwin B. Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 2014;306:L591-603. [PMID: 24464809 DOI: 10.1152/ajplung.00335.2013] [Cited by in Crossref: 99] [Cited by in F6Publishing: 97] [Article Influence: 12.4] [Reference Citation Analysis]
58 Ziegler A, Gonzalez L, Blikslager A. Large Animal Models: The Key to Translational Discovery in Digestive Disease Research. Cell Mol Gastroenterol Hepatol 2016;2:716-24. [PMID: 28090566 DOI: 10.1016/j.jcmgh.2016.09.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
59 Berczeli O, Vizvári E, Katona M, Török D, Szalay L, Rárosi F, Németh I, Rakonczay Z, Hegyi P, Ding C, Tóth-Molnár E. Novel Insight Into the Role of CFTR in Lacrimal Gland Duct Function in Mice. Invest Ophthalmol Vis Sci 2018;59:54-62. [PMID: 29305607 DOI: 10.1167/iovs.17-22533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
60 Dreano E, Bacchetta M, Simonin J, Galmiche L, Usal C, Slimani L, Sadoine J, Tesson L, Anegon I, Concordet JP, Hatton A, Vignaud L, Tondelier D, Sermet-Gaudelus I, Chanson M, Cottart CH. Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9. Animal Model Exp Med 2019;2:297-311. [PMID: 31942562 DOI: 10.1002/ame2.12091] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
61 Briard B, Mislin GLA, Latgé JP, Beauvais A. Interactions between Aspergillus fumigatus and Pulmonary Bacteria: Current State of the Field, New Data, and Future Perspective. J Fungi (Basel) 2019;5:E48. [PMID: 31212791 DOI: 10.3390/jof5020048] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
62 Keiser NW, Engelhardt JF. Gene delivery to the airway. Curr Protoc Hum Genet 2013;Chapter 13:Unit 13.9. [PMID: 23853081 DOI: 10.1002/0471142905.hg1309s78] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
63 Yu M, Sun X, Tyler SR, Liang B, Swatek AM, Lynch TJ, He N, Yuan F, Feng Z, Rotti PG, Choi SH, Shahin W, Liu X, Yan Z, Engelhardt JF. Highly Efficient Transgenesis in Ferrets Using CRISPR/Cas9-Mediated Homology-Independent Insertion at the ROSA26 Locus. Sci Rep 2019;9:1971. [PMID: 30760763 DOI: 10.1038/s41598-018-37192-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
64 McCarron A, Donnelley M, Parsons D. Airway disease phenotypes in animal models of cystic fibrosis. Respir Res 2018;19:54. [PMID: 29609604 DOI: 10.1186/s12931-018-0750-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
65 Tang Y, Yan Z, Lin S, Huntemann ED, Feng Z, Park SY, Sun X, Yuen E, Engelhardt JF. Repeat Dosing of AAV2.5T to Ferret Lungs Elicits an Antibody Response That Diminishes Transduction in an Age-Dependent Manner. Mol Ther Methods Clin Dev 2020;19:186-200. [PMID: 33209961 DOI: 10.1016/j.omtm.2020.09.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]